Meridian Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,534
Closed -$1.04M 832
2026
Q1
$1.04M Buy
16,534
+1,981
+14% +$158K 0.04% 353
2025
Q4
$1.39M Buy
14,553
+9,005
+162% +$883K 0.05% 286
2025
Q3
$542K Buy
5,548
+3,392
+157% +$351K 0.02% 455
2025
Q2
$232K Buy
2,156
+40
+2% +$4.05K 0.01% 614
2025
Q1
$213K Buy
+2,116
New +$213K 0.01% 592

Other funds holding BSX

Meridian Wealth Management's BSX Position: Q2 2026 in Review

Meridian Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 16,534 shares — an estimated $1.04M sold.

Meridian Wealth Management first reported a position in BSX in Q1 2025 and held it in 5 quarters. The position peaked at $1.39M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Meridian Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Meridian Wealth Management sold 16,534 Boston Scientific shares in Q2 2026, an estimated $1.04M.
  • Meridian Wealth Management first reported a position in Boston Scientific in Q1 2025 and held it in 5 quarters.
  • Meridian Wealth Management's Boston Scientific position peaked at $1.39M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.